Abstract
Cancer of the pancreas is a neoplasm which occurs infrequently, although cases are increasing and the death rate is very high death. The incidence of this neoplasm in the United States is around 11 cases per 100,000 inhabitants, equating to around 30,000 new cases per year [1, 2]. In Europe, the incidence is around 5.2–8.7 cases per 100,000 inhabitants, with a lot of variations among the different nations [3, 4]. The lowest incidences have been recorded in Africa and in Asia, at 2 cases per 100,000 inhabitants, although over the last 40 years a large increase in the number of cases in Japan has been noticed, with 19,700 new cases per year (15 per 100,000 inhabitants) [2, 5] (Table 13.1). The growing trend appears to be mainly related to two factors: the rise in average age, which is the main risk factor for all the principal gastroenteric neoplasms, and the spread of tobacco-smoking habits.
Keywords
- Pancreatic Cancer
- Chronic Pancreatitis
- Familial Adenomatous Polyposis
- Pancreatic Carcinoma
- Pancreatic Neoplasm
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ries LAG, Melbert D, Krapcho M et al (eds) (2008) SEER Cancer Statistics Review, 1975–2005, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2005/, based on November 2007 SEER data submission, posted to the SEER web site, 2008
Japan National Cancer Center (2007) Cancer Statistic in Japan 2007. http://ncc.go.jp/
Moossa AR (1991) Tumours of the pancreas. In: Moossa AR, Schimpf SC, Rabson MC (eds) Comprehensive textbook of oncology, vol 1, 2nd edn. Williams and Wilkins, Baltimore, pp 958–988
Mori K, Ikei S, Yamane T et al (1990) Pathological factors influencing survival of carcinoma of the ampulla of Vater. Eur J Surg Oncol 16(3):183–188
Lin Y, Tamakoshi A, Wakai K et al (1998) Descriptive epidemiology of pancreatic cancer in Japan. J Epidemiol 8(1):52–59
Parkin DM, Muir C, Whelan SL et al (1992) Cancer incidence in five continents. IARC Scientific Publications, Lyon 120:1–1033
Fraumeni JF Jr (1975) Cancers of the pancreas and biliary tract: epidemiological considerations. Cancer Res 35(11 Pt 2):3437–3446
Phillips AR, Lawes CM, Cooper GJ, Windsor JA (2002) Ethnic disparity of pancreatic cancer in New Zealand. Int J Gastrointest Cancer 31(1–3):137–145
McCredie M, Cox B, Stewart JH (2000) Smoking-related cancers in Maori and non-Maori in New Zealand, 1974–1993: fewer bladder cancers among Maori. Asian Pac J Cancer Prev 1(3):221–225
Gold EB, Goldin SB (1998) Epidemiology of and risk factors for pancreatic cancer [review]. Surg Oncol Clin N Am 7(1):67–91
Pernick NL, Sarkar FH, Philip PA et al (2003) Clinicopathologic analysis of pancreatic adenocarcinoma in African Americans and Caucasians. Pancreas 26:28–32
Parkin DM, Bray F, Ferlay F, Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74–108
Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83(1):18–29. Erratum in: Int J Cancer 83(6):870–873
Phoa SS, Tilleman EH, van Delden OM et al (2005) Value of CT criteria in predicting survival in patients with potentially resectable pancreatic head carcinoma. J Surg Oncol 91(1):33–40
Andren-Sandberg A, Neoptolemos JP (2002) Resection for pancreatic cancer in the new millennium. Pancreatology 2:431–439
Bramhall SR, Allum WH, Jones AG et al (1995) Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease in the West Midlands: an epidemiological study. Br J Surg 82:111–115
Shore S, Raraty M, Ghaneh P et al (2003) Chemotherapy for pancreatic cancer. Aliment Pharmacol Ther 18:1049–1069
Neoptolemos JP, Dunn JA, Stocken DD et al (2001) Adjuvant chemoradiotherapy and chemotherapy in respectable pancreatic cancer: a randomized controlled trial. Lancet 358:1576–1585
Yeo CJ, Cameron JL, Lillemoe KD et al (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 221(6):721–731
Ariyama J, Suyama M, Satoh K, Wakabayashi K (1998) Endoscopic ultrasound and intraductal ultrasound in the diagnosis of small pancreatic tumors. Abdom Imaging 23(4):380–386
Lochan R, Daly AK, Reeves HL, Charnley RM (2008) Genetic susceptibility in pancreatic ductal adenocarcinoma. Br J Surg 95(1):22–32
Silverman DT, Dunn JA, Hoover RN et al (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 86:1510–1516
Mack TM, Yu MC, Hanisch R et al (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76:49–60
Lin Y, Tamakoshi A, Kawamura T et al (2002) A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control 13:249–254
Akiba S, Hirayama T (1990) Cigarette smoking and cancer mortality risk in Japanese men and women — results from reanalysis of the six-prefecture cohort study data. Environ Health Perspect 87:19–26
Fuchs CS, Colditz GA, Stampfer MJ et al (1996) A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156(19):2255–2260
Doll R, Peto R, Wheatley K et al (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. Br Med J 309:901–911
Stolzenberg-Solomon RZ, Cross AJ, Silverman DT et al (2007) Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev 16(12):2664–2675
Baghurst PA, McMichael AJ, Slavotinek AH et al (1991) A case-control study of diet and cancer of the pancreas. Am J Epidemiol 134:167–179
Bueno de Mesquita HB, Maisonneuve P, Moerman CJ et al (1991) Intake of foods and nutrients and cancer of the exocrine pancreas: a population-based case-control study in the Netherlands. Int J Cancer 48:540–549
Ghadirian P, Simard A, Baillargeon J et al (1991–1992) Nutritional factors and pancreatic cancer in the francophone community in Montreal, Canada. Int J Cancer 47:1–6; 52:17–23
Ghadirian P, Thouez JP, PetitClerc C (1991) International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detect Prev 15:357–362
Zatonski W, Przewozniak K, Howe GR et al (1991) Nutritional factors and pancreatic cancer: a case-control study from south-west Poland. Int J Cancer 48:390–394
Howe GR, Ghadirian P, Bueno de Mesquita HB et al (1992) A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 51:365–372
Stolzenberg-Solomon RZ, Pietinen P, Taylor PR et al (2002) Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 155:783–792
Ohba S, Nishi M, Miyake H (1996) Eating habits and pancreas cancer. Int J Pancreatol 20:37–42
Ojajarvi A, Partanen T, Ahlbom A et al (2001) Risk of pancreatic cancer in workers exposed to chlorinated hydrocarbon solvents and related compounds: a meta-analysis. Am J Epidemiol 153:841–850
Collins JJ, Esmen NA, Hall TA (2001) A review and meta-analysis of formaldehyde exposure and pancreatic cancer. Am J Ind Med 39:336–345
McCallion K, Mitchell RM, Wilson RH, Kee F et al (2001) Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut 48:522–525
Kauppinen T, Partanen T, Degerth R et al (1995) Pancreatic cancer and occupational exposures. Epidemiology 6:498–502
Alguacil J, Kauppinen T, Porta M et al (2000) Risk of pancreatic cancer and occupational exposures in Spain. PANKRAS II Study Group. Ann Occup Hyg 44:391–403
Hoppin JA, Tolbert PE, Holly EA et al (2000) Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev 9:199–205
Porta M, Malats N, Jariod M et al (1999) Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. Lancet 354:2125–2129
Fryzek JP, Garabrant DH, Harlow SD et al (1997) A case-control study of self-reported exposures to pesticides and pancreas cancer in southeastern Michigan. Int J Cancer 72:62–67
Michaud DS, Giovannucci E, Willett WC et al (2001) Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286(8):921–929
Ye W, Lagergren J, Weiderpass E et al (2002) Alcohol abuse and the risk of pancreatic cancer. Gut 51:236–239
Partanen T, Hemminki K, Vainio H, Kauppinen T (1995) Coffee consumption not associated with risk of pancreas cancer in Finland. Prev Med 24(2):213–216
Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer Causes Control 5(5):401–408
Michaud DS, Giovannucci E, Willett WC et al (2001) Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev 10(5):429–437
Brand RE, Lynch HT (2006) Genotype/phenotype of familial pancreatic cancer [review]. Endocrinol Metab Clin North Am 35(2):405–415, xi
Lal G, Liu G, Schmocker B et al (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60:409–416
Kern SE, Hruban RH, Hidalgo M et al (2002) An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. Cancer Biol Ther 1:607–613
Rulyak SJ, Lowenfels AB, Maisonneuve P et al (2003) Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology 124:1292–1299
Maisonneuve P, FitzSimmons SC, Neglia JP et al (2003) Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 95:381–387
Neglia JP, FitzSimmons SC, Maisonneuve P et al (1995) The risk of cancer among patients with cystic fibrosis. N Engl J Med 332:494–499
Su GH, Hruban RH, Bansal RK et al (1999) Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154:1835–1840
Efthimiou E, Crnogorac-Jurcevic T, Lemoine NR (2001) Inherited predisposition to pancreatic cancer. Gut 48:143–147
Goldstein AM, Fraser MC, Streuwing JP et al (1995) Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 333:970–974
Hahn SA, Bartsch DK (2005) Genetics of hereditary pancreatic carcinoma. Clin Lab Med 25(1):117–133
Greer JB, Whitcomb DC, Brand RE (2007) Genetic predisposition to pancreatic cancer: a brief review. Am J Gastroenterol 102(11):2564–2569
Harris CC (1989) Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10(9):1563–1566
Foster JR, Idle JR, Hardwick JP et al (1993) Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis. J Pathol 169:457–463
Duell EJ, Holly EA, Bracci PM et al (2002) A population-based case-control study of polymorphisms in carcinogen-metabolizing genes, smoking and pancreatic adenocarcinoma risk. J Natl Cancer Inst 94:297–306
Bartsch H, Malaveille C, Lowenfels AB et al (1998) Genetic polymorphism of N-acetyltransferases, glutathione S transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. The International Pancreatic Disease Study Group. Eur J Cancer Prev 7:215–223
Ockenga J, Vogel A, Teich N et al (2003) UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer. Gastroenterology 124:1802–1808
Lowenfels AB, Maisonneuve P, Cavallini G et al (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328:1433–1437
Lowenfels AB, Maisonneuve P, DiMagno EP et al (1997) Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89:442–446
Chari ST, Mohan V, Pitchumoni CS et al (1994) Risk of pancreatic carcinoma in tropical calcifying pancreatitis: an epidemiologic study. Pancreas 9:62–66
Lowenfels AB, Maisonneuve P, Whitcomb DC et al (2001) Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286(2):169–170
Everhart J, Wright D (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A metaanalysis. JAMA 273:1605–1609
Chari ST, Leibson CL, Rabe KG et al (2005) Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology 129(2):504–511
Huxley R, Ansary-Moghaddam A, Berrington de Gonz ález A et al (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92(11):2076–2083
Karmody AJ, Kyle J (1969) The association between carcinoma of the pancreas and diabetes mellitus. Br J Surg 56:362–364
Permert J, Adrian TE, Jacobsson P et al (1993) Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 165:61–66
Permert J, Ihse I, Jorfeldt L et al (1993) Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 159:101–107
Chu TM (1997) Molecular diagnosis of pancreas carcinoma. J Clin Lab Anal 11:225–231
Vimalachandran D, Ghaneh P, Costello E, Neoptolemos JP (2004) Genetics and prevention of pancreatic cancer. Cancer Control 11(1):6–14
Norell SE, Ahlbom A, Erwald R et al (1986) Diet and pancreatic cancer: a case-control study. Am J Epidemiol 124:894–902
Kokawa A, Kondo H, Gotoda T et al (2001) Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer 91:333–338
Anderson KE, Johnson TW, Lazovich D et al (2002) Association between nonsteroidal antiinflammatory drug use and the incidence of pancreatic cancer. J Natl Cancer Inst 94:1168–1171
Larsson SC, Giovannucci E, Bergkvist L, Wolk A (2006) Aspirin and nonsteroidal antiinflammatory drug use and risk of pancreatic cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 15(12):2561–2564
Doucas H, Garcea G, Neal CP et al (2006) Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention [review]. Pancreatology 6(5):429–439
Holly EA, Chaliha I, Bracci PM, Gautam M (2004) Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2(6):510–517
Niederau C, Grendell JH (1992) Diagnosis of pancreatic carcinoma. Imaging techniques and tumor markers. Pancreas 7(1):66–86
Steinberg W (1990) The clinical utility of the CA 19-9 tumor-associated antigen [review]. Am J Gastroenterol 85(4):350–355
Saisho H, Yamaguchi T (2004) Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography. Pancreas 28(3):273–278
Yasuda K, Mukai H, Nakajima M (1995) Endoscopic ultrasonography diagnosis of pancreatic cancer. Gastrointest Endosc Clin North Am 5(4):699–712
Durie P, Lerch MM, Lowenfels AB et al (2002) Genetic disorders of the exocrine pancreas. An overview and update. Karger, Basel
McFaul CD, Greenhalf W, Earl J et al (2006) Anticipation in familial pancreatic cancer. Gut 55:252–258
Brentnall TA, Bronner MP, Byrd DR et al (1999) Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer. Ann Intern Med 131:247–255
Brentnall TA (2000) Cancer surveillance of patients from familial pancreatic cancer kindreds. Med Clin North Am 84:707–718
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Mocchegiani, F., Ghiselli, R., Cappelletti, M., Saba, V. (2009). Epidemiology, Risk Factors, and Prevention of Pancreatic Cancer. In: Surgical Treatment of Pancreatic Diseases. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0856-4_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-0856-4_13
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0855-7
Online ISBN: 978-88-470-0856-4
eBook Packages: MedicineMedicine (R0)